The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Embriva
Ascorbic Acid, Cholecalciferol, Thiamine, Pyridoxal Phosphate, Folic Acid, Methylcobalamin, Calcium Carbonate, Ferrous Gluconate, Potassium Iodide · PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg/1; POTASSIUM IODIDE .15 mg/1; ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL .0125 mg/1; THIAMINE 1.4 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1 mg/1; CALCIUM CARBONATE 200 mg/1; FERROUS GLUCONATE 13 mg/1 · Tablet · Oral · Oncora Pharma, LLC
NDC 85477-0322-30 · 30 TABLET in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ascorbic Acid, Cholecalciferol, Thiamine, Pyridoxal Phosphate, Folic Acid, Methylcobalamin, Calcium Carbonate, Ferrous Gluconate, Potassium Iodide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Oncora Pharma LLC | ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL 12.5 ug/1; THIAMINE 1.4 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1000 ug/1; CALCIUM CARBONATE 200 mg/1; FERROUS GLUCONATE 13 mg/1; POTASSIUM IODIDE .15 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Oncora Pharma, LLC | PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg/1; POTASSIUM IODIDE .15 mg/1; ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL .0125 mg/1; THIAMINE 1.4 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1 mg/1; CALCIUM CARBONATE 200 mg/1; FERROUS GLUCONATE 13 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Oncora Pharma LLC | ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL 200 mg/1; THIAMINE 12.5 ug/1; PYRIDOXAL PHOSPHATE ANHYDROUS 13 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1000 ug/1; CALCIUM CARBONATE .15 mg/1; FERROUS GLUCONATE 2.5 mg/1; POTASSIUM IODIDE 1.4 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Oncora Pharma, LLC | PYRIDOXAL PHOSPHATE ANHYDROUS 125 mg/1; POTASSIUM IODIDE 200 mg/1; ASCORBIC ACID .0125 mg/1; CHOLECALCIFEROL 13 mg/1; THIAMINE 1 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN .15 mg/1; CALCIUM CARBONATE 2.5 mg/1; FERROUS GLUCONATE 1.4 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Oncora Pharma LLC | ASCORBIC ACID 125 mg/1; CALCIUM CARBONATE 200 mg/1; CHOLECALCIFEROL 12.5 ug/1; FERROUS GLUCONATE 13 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1000 ug/1; POTASSIUM IODIDE .15 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg/1; THIAMINE 1.4 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Oncora Pharma, LLC | ASCORBIC ACID 125 mg/1; CALCIUM CARBONATE 200 mg/1; CHOLECALCIFEROL .0125 mg/1; FERROUS GLUCONATE 13 mg/1; FOLIC ACID 1 mg/1; METHYLCOBALAMIN 1 mg/1; POTASSIUM IODIDE .15 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg/1; THIAMINE 1.4 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Embriva — NDC 85477-0322-30," retrieved September 3, 2026, https://drugdashboards.com/drug/85477032230.
Free to cite with attribution — see how the data is put together.